The Cancer Letter

Inside information on cancer research and drug development

Vol.
34
No.
12
December 30, 2011Dec 30, 2011
Free
DOWNLOAD THE PDF

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

Perifosine Increases PFS In Phase II Study

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

Single-Letter Mutation Found Responsible For Waldenstrom’s

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

Gene Expression Analyses Can Guide MDS Treatments

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

CTCs Do Not Affect Survival, But Could Signal Metastases

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

Trials Approved by NCI CTEP For the Month of December

FDA Grants Orphan Designation To Photofrin for Mesothelioma

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account